262 related articles for article (PubMed ID: 36175960)
1. Clinical characteristics, healthcare use, and annual costs among patients with dystrophic epidermolysis bullosa.
Feinstein JA; Bruckner AL; Chastek B; Anderson A; Roman J
Orphanet J Rare Dis; 2022 Sep; 17(1):367. PubMed ID: 36175960
[TBL] [Abstract][Full Text] [Related]
2. Assessment of the Timing of Milestone Clinical Events in Patients With Epidermolysis Bullosa From North America.
Feinstein JA; Jambal P; Peoples K; Lucky AW; Khuu P; Tang JY; Lara-Corrales I; Pope E; Wiss K; Hook KP; Levin LE; Morel KD; Paller AS; McCuaig CC; Powell J; Eichenfield LF; Price H; Levy ML; Schachner LA; Browning JC; Bayliss S; Jahnke M; Shwayder T; Glick SA; Bruckner AL
JAMA Dermatol; 2019 Feb; 155(2):196-203. PubMed ID: 30586139
[TBL] [Abstract][Full Text] [Related]
3. The clinical spectrum of dystrophic epidermolysis bullosa.
Horn HM; Tidman MJ
Br J Dermatol; 2002 Feb; 146(2):267-74. PubMed ID: 11903238
[TBL] [Abstract][Full Text] [Related]
4. A systematic literature review of the disease burden in patients with recessive dystrophic epidermolysis bullosa.
Tang JY; Marinkovich MP; Lucas E; Gorell E; Chiou A; Lu Y; Gillon J; Patel D; Rudin D
Orphanet J Rare Dis; 2021 Apr; 16(1):175. PubMed ID: 33849616
[TBL] [Abstract][Full Text] [Related]
5. Understanding the socioeconomic costs of dystrophic epidermolysis bullosa in Europe: a costing and health-related quality of life study.
Angelis A; Mellerio JE; Kanavos P
Orphanet J Rare Dis; 2022 Sep; 17(1):346. PubMed ID: 36068590
[TBL] [Abstract][Full Text] [Related]
6. Hereditary epidermolysis bullosa: clinical-epidemiological profile of 278 patients at a tertiary hospital in São Paulo, Brazil.
Thien CI; Bessa VR; Miotto IZ; Samorano LP; Rivitti-Machado MC; Oliveira ZNP
An Bras Dermatol; 2024; 99(3):380-390. PubMed ID: 38403552
[TBL] [Abstract][Full Text] [Related]
7. Clinical and allelic heterogeneity in dystrophic epidermolysis bullosa- lessons from an Indian cohort.
Gupta D; Jayashankar C; Srinivas M; Baraka Vishwanathan G; Reddy KR; Kubba A; Batrani M; Hiremagalore R
PLoS One; 2023; 18(8):e0289558. PubMed ID: 37556444
[TBL] [Abstract][Full Text] [Related]
8. Cutaneous Squamous Cell Carcinoma in Epidermolysis Bullosa: a 28-year Retrospective Study.
Robertson SJ; Orrin E; Lakhan MK; O'Sullivan G; Felton J; Robson A; Greenblatt DT; Bernardis C; McGrath JA; Martinez AE; Mellerio JE
Acta Derm Venereol; 2021 Aug; 101(8):adv00523. PubMed ID: 34230977
[TBL] [Abstract][Full Text] [Related]
9. Epidermolysis Bullosa (EB) Acquisita in an Adult Patient with Previously Unrecognized Mild Dystrophic EB and Biallelic COL7A1 Mutations.
Guerra L; Condorelli AG; Fortugno P; Calabresi V; Pedicelli C; Di Zenzo G; Castiglia D
Acta Derm Venereol; 2018 Apr; 98(4):411-415. PubMed ID: 29182795
[TBL] [Abstract][Full Text] [Related]
10. Ophthalmologic Approach in Epidermolysis Bullosa: A Cross-Sectional Study With Phenotype-Genotype Correlations.
Mellado F; Fuentes I; Palisson F; I Vergara J; Kantor A
Cornea; 2018 Apr; 37(4):442-447. PubMed ID: 29384803
[TBL] [Abstract][Full Text] [Related]
11. Genotype and phenotype correlations in 441 patients with epidermolysis bullosa from China.
Chen F; Wei R; Deng D; Zhang X; Cao Y; Pan C; Wang Y; Cao Q; Wang J; Zeng M; Huang L; Gu Y; Yao Z; Li M
J Eur Acad Dermatol Venereol; 2023 Feb; 37(2):411-419. PubMed ID: 36287101
[TBL] [Abstract][Full Text] [Related]
12. Innovations in the Treatment of Dystrophic Epidermolysis Bullosa (DEB): Current Landscape and Prospects.
Hou PC; Del Agua N; Lwin SM; Hsu CK; McGrath JA
Ther Clin Risk Manag; 2023; 19():455-473. PubMed ID: 37337559
[TBL] [Abstract][Full Text] [Related]
13. Therapies for cutaneous squamous cell carcinoma in recessive dystrophic epidermolysis bullosa: a systematic review of 157 cases.
Hwang A; Kwon A; Miller CH; Reimer-Taschenbrecker A; Paller AS
Orphanet J Rare Dis; 2024 May; 19(1):206. PubMed ID: 38769503
[TBL] [Abstract][Full Text] [Related]
14. QR-313, an Antisense Oligonucleotide, Shows Therapeutic Efficacy for Treatment of Dominant and Recessive Dystrophic Epidermolysis Bullosa: A Preclinical Study.
Bornert O; Hogervorst M; Nauroy P; Bischof J; Swildens J; Athanasiou I; Tufa SF; Keene DR; Kiritsi D; Hainzl S; Murauer EM; Marinkovich MP; Platenburg G; Hausser I; Wally V; Ritsema T; Koller U; Haisma EM; Nyström A
J Invest Dermatol; 2021 Apr; 141(4):883-893.e6. PubMed ID: 32946877
[TBL] [Abstract][Full Text] [Related]
15. Age and etiology of childhood epidermolysis bullosa mortality.
Hon KL; Li JJ; Cheng BL; Luk DC; Murrell DF; Choi PC; Leung AK
J Dermatolog Treat; 2015 Apr; 26(2):178-82. PubMed ID: 24724596
[TBL] [Abstract][Full Text] [Related]
16. Squamous cell carcinoma complicating epidermolysis bullosa in a 6-year-old girl.
Shivaswamy KN; Sumathy TK; Shyamprasad AL; Ranganathan C
Int J Dermatol; 2009 Jul; 48(7):731-3. PubMed ID: 19570079
[TBL] [Abstract][Full Text] [Related]
17. A rare case of recessive dystrophic epidermolysis bullosa with aplasia cutis and pyloric stenosis.
Sawka E; Dhossche J; Funk T
JAAD Case Rep; 2021 Jan; 7():134-136. PubMed ID: 33426253
[No Abstract] [Full Text] [Related]
18. Immunofluorescence mapping, electron microscopy and genetics in the diagnosis and sub-classification of inherited epidermolysis bullosa: a single-centre retrospective comparative study of 87 cases with long-term follow-up.
Rossi S; Castiglia D; Pisaneschi E; Diociaiuti A; Stracuzzi A; Cesario C; Mariani R; Floriddia G; Zambruno G; Boldrini R; Abeni D; Novelli A; Alaggio R; El Hachem M
J Eur Acad Dermatol Venereol; 2021 Apr; 35(4):1007-1016. PubMed ID: 33274474
[TBL] [Abstract][Full Text] [Related]
19. Management of acute sloughing of the esophageal lining in patients with dystrophic epidermolysis bullosa-A series of six pediatric patients.
Bageta ML; Yerlett N; Rybak A; Balboa PL; Petrof G; Martinez AE
Pediatr Dermatol; 2023; 40(6):1010-1014. PubMed ID: 37496109
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
